Miglitol Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 25 mg, 50 mg, 100 mg

Reference Brands: Glyset (USA), Diastabol (EU)

Category: Diabetes

Miglitol is an oral antidiabetic medication used to manage type 2 diabetes. It works by inhibiting enzymes in the intestine that break down carbohydrates, helping to reduce the rise in blood glucose after meals. It is usually taken three times a day with the first bite of food. Miglitol is often used together with diet, exercise, or in combination with other antidiabetic drugs. Miglitol is available in Tablets and strengths such as 25 mg, 50 mg, 100 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Miglitol is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Miglitol can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Miglitol is an oral antidiabetic medication used for the management of type 2 diabetes mellitus. It belongs to the class of alpha-glucosidase inhibitors, which work by delaying the absorption of carbohydrates in the small intestine. This action helps control postprandial (after-meal) blood sugar spikes, making it an effective option for patients whose blood glucose levels are not adequately controlled with diet alone or in combination with other antidiabetic therapies.

Miglitol is typically administered in tablet form and is taken with the first bite of each main meal. Its effectiveness depends on consistent usage alongside a proper diet and exercise regimen. By slowing carbohydrate breakdown, Miglitol reduces sudden increases in blood sugar, supporting better overall glycemic control. It is particularly useful for patients who need targeted control of post-meal glucose levels and can be combined with other oral antidiabetic medications when prescribed by a healthcare professional.

Healthcare providers monitor patients for gastrointestinal side effects, such as bloating or diarrhea, which are commonly associated with Miglitol. Regular monitoring of blood glucose and overall metabolic health is recommended to ensure optimal results.

Overall, Miglitol is a reliable and effective oral antidiabetic agent for managing type 2 diabetes, helping patients maintain stable blood sugar levels and supporting long-term metabolic health when used as part of a comprehensive treatment plan.